ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/01/23 | 2,134 | 2,167 | 2,125 | 2,129 | -11 | -0.5% | 601,600 |
2020/01/22 | 2,135 | 2,193 | 2,131 | 2,140 | +6 | +0.3% | 917,900 |
2020/01/21 | 2,133 | 2,153 | 2,121 | 2,134 | -5 | -0.2% | 373,900 |
2020/01/20 | 2,142 | 2,152 | 2,123 | 2,139 | -9 | -0.4% | 365,500 |
2020/01/17 | 2,142 | 2,159 | 2,135 | 2,148 | -2 | -0.1% | 636,300 |
2020/01/16 | 2,118 | 2,167 | 2,115 | 2,150 | +11 | +0.5% | 774,200 |
2020/01/15 | 2,110 | 2,152 | 2,108 | 2,139 | +35 | +1.7% | 838,600 |
2020/01/14 | 2,129 | 2,129 | 2,092 | 2,104 | -11 | -0.5% | 740,500 |
2020/01/10 | 2,038 | 2,116 | 2,038 | 2,115 | +68 | +3.3% | 987,500 |
2020/01/09 | 2,052 | 2,079 | 2,030 | 2,047 | +35 | +1.7% | 1,038,000 |
2020/01/08 | 2,101 | 2,110 | 1,977 | 2,012 | -105 | -5% | 2,841,100 |
2020/01/07 | 2,127 | 2,156 | 2,115 | 2,117 | ±0 | ±0% | 1,107,200 |
2020/01/06 | 2,150 | 2,176 | 2,110 | 2,117 | -54 | -2.5% | 1,633,800 |
2019/12/30 | 2,260 | 2,261 | 2,162 | 2,171 | -98 | -4.3% | 1,765,500 |
2019/12/27 | 2,272 | 2,295 | 2,242 | 2,269 | -3 | -0.1% | 965,900 |
2019/12/26 | 2,206 | 2,299 | 2,206 | 2,272 | +44 | +2% | 2,002,800 |
2019/12/25 | 2,227 | 2,248 | 2,196 | 2,228 | +6 | +0.3% | 1,393,800 |
2019/12/24 | 2,193 | 2,225 | 2,146 | 2,222 | +41 | +1.9% | 2,159,000 |
2019/12/23 | 2,200 | 2,206 | 2,147 | 2,181 | +16 | +0.7% | 1,369,700 |
2019/12/20 | 2,212 | 2,215 | 2,158 | 2,165 | -37 | -1.7% | 925,200 |
2019/12/19 | 2,190 | 2,214 | 2,177 | 2,202 | +12 | +0.5% | 612,400 |
2019/12/18 | 2,210 | 2,226 | 2,173 | 2,190 | -19 | -0.9% | 805,400 |
2019/12/17 | 2,150 | 2,209 | 2,144 | 2,209 | +59 | +2.7% | 1,083,700 |
2019/12/16 | 2,168 | 2,197 | 2,137 | 2,150 | -55 | -2.5% | 1,568,300 |
2019/12/13 | 2,268 | 2,268 | 2,204 | 2,205 | -49 | -2.2% | 1,543,600 |
2019/12/12 | 2,260 | 2,267 | 2,228 | 2,254 | -13 | -0.6% | 818,600 |
2019/12/11 | 2,261 | 2,295 | 2,247 | 2,267 | +18 | +0.8% | 931,700 |
2019/12/10 | 2,284 | 2,296 | 2,248 | 2,249 | -24 | -1.1% | 854,200 |
2019/12/09 | 2,315 | 2,342 | 2,260 | 2,273 | -44 | -1.9% | 1,269,800 |
2019/12/06 | 2,230 | 2,320 | 2,218 | 2,317 | +83 | +3.7% | 1,467,100 |
2019/12/05 | 2,321 | 2,334 | 2,230 | 2,234 | -83 | -3.6% | 1,856,000 |
2019/12/04 | 2,283 | 2,327 | 2,278 | 2,317 | +9 | +0.4% | 978,700 |
2019/12/03 | 2,248 | 2,308 | 2,236 | 2,308 | +39 | +1.7% | 970,500 |
2019/12/02 | 2,313 | 2,340 | 2,263 | 2,269 | -20 | -0.9% | 1,133,600 |
2019/11/29 | 2,347 | 2,399 | 2,280 | 2,289 | +17 | +0.7% | 2,595,600 |
2019/11/28 | 2,253 | 2,314 | 2,247 | 2,272 | +24 | +1.1% | 1,541,400 |
2019/11/27 | 2,273 | 2,273 | 2,230 | 2,248 | -16 | -0.7% | 964,000 |
2019/11/26 | 2,248 | 2,281 | 2,242 | 2,264 | +20 | +0.9% | 1,270,800 |
2019/11/25 | 2,315 | 2,321 | 2,241 | 2,244 | -93 | -4% | 2,122,200 |
2019/11/22 | 2,343 | 2,349 | 2,312 | 2,337 | -8 | -0.3% | 943,200 |
2019/11/21 | 2,330 | 2,345 | 2,269 | 2,345 | +13 | +0.6% | 1,390,500 |
2019/11/20 | 2,314 | 2,347 | 2,295 | 2,332 | +49 | +2.1% | 1,501,700 |
2019/11/19 | 2,258 | 2,283 | 2,243 | 2,283 | +15 | +0.7% | 953,400 |
2019/11/18 | 2,250 | 2,272 | 2,224 | 2,268 | +28 | +1.3% | 998,000 |
2019/11/15 | 2,216 | 2,253 | 2,185 | 2,240 | +31 | +1.4% | 1,358,200 |
2019/11/14 | 2,282 | 2,308 | 2,201 | 2,209 | -58 | -2.6% | 2,005,100 |
2019/11/13 | 2,530 | 2,535 | 2,250 | 2,267 | -235 | -9.4% | 6,051,800 |
2019/11/12 | 2,520 | 2,529 | 2,472 | 2,502 | -11 | -0.4% | 1,299,400 |
2019/11/11 | 2,484 | 2,544 | 2,484 | 2,513 | +36 | +1.5% | 984,300 |
2019/11/08 | 2,538 | 2,539 | 2,468 | 2,477 | -36 | -1.4% | 958,300 |
1151~
1200
件表示中 / 4943件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 125,100円 | +197.7% | - | 0.00% | 51.12倍 | 1.63倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
持田薬 | 346,000円 | +3.0% | +27.5% | 2.31% | 21.90倍 | 0.95倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 233,800円 | +9.6% | +17.5% | 1.97% | 13.21倍 | 1.30倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 393,500円 | +11.1% | +20.6% | 3.05% | 23.05倍 | 0.92倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
杏林製薬 | 153,100円 | +3.2% | +4.5% | 3.40% | 17.59倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム